Working in a mouse model, UC Davis researchers are able to distinguish brain cells activated by a psychedelic drug. This image shows the prefrontal cortex of a mouse injected with scFLARE2 (purple) ...

Quick-acting targeted therapies with minimal side effects are an urgent need for the treatment of anxiety-related disorders. While delta opioid receptor (DOP) agonists have shown 'anxiolytic' or ...

New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics. The anti-anxiety andhallucination-inducing qualities of ...